These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 358100)

  • 1. Investigation and determination of the antifibrinolytic properties of dipeptides and synthetic compounds.
    Dupin JP; Boisseau M; Brasington RD; Mesnard P
    Pathol Biol (Paris); 1978; 26(5):233-9. PubMed ID: 358100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antifibrinolytic agents, a new class of drugs].
    Markwardt F
    Internist (Berl); 1966 Aug; 7(8):400-5. PubMed ID: 4863412
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of epsilon-aminocaproyl-S-benzyl-L-cysteine on the activity of plasminogen activators.
    Bruzgo I; Midura-Nowaczek K; Kaczyńska J; Krajewska D
    Acta Pol Pharm; 2009; 66(1):37-40. PubMed ID: 19226966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of epsilon-aminocaproiloaminoacids on the amidolytic activity of tissue plasminogen activator, urokinase and kallikrein.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Markowska A
    Acta Pol Pharm; 2004; 61(1):75-6. PubMed ID: 15259861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of dipeptide derivatives of S-substituted cysteines on the time of fibrinolysis.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Rocz Akad Med Bialymst; 1996; 41(2):412-6. PubMed ID: 9020554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis and properties of antifibrinolytic dipeptides containing E-aminocaproic acid].
    Midura-Nowaczek K; Bruzgo I; Popławski J; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1992; 49(1-2):89-92. PubMed ID: 8769082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the influence of protease inhibitors and synthetic antifibrinolytic agents on the bleeding time].
    Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):174-8. PubMed ID: 4174655
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the use of p-aminomethyl benzoic acid ethyl ester as antifibrinolytic agent].
    Markwardt F; Klöcking HP; Vogel G
    Z Gesamte Inn Med; 1967 Oct; 22(19):569-74. PubMed ID: 5596621
    [No Abstract]   [Full Text] [Related]  

  • 13. Immobilization of plasminogen activator, urokinase, on nylon.
    Sugitachi A; Takagi K; Imaoka S; Kosaki G
    Thromb Haemost; 1978 Apr; 39(2):426-36. PubMed ID: 580991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and activity of N alpha-(epsilon-aminocaproyl)-alanines and N epsilon-(epsilon-aminocaproyl)-caproic acid.
    Midura-Nowaczek K; Bruzgo I; Popławski J; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1995; 52(6):505-7. PubMed ID: 8960269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

  • 16. [The inhibition of endothelial cell proliferation by esters of 4-aminomethylbenzoic acid (pamba)].
    Beyer S; Pilgrim H
    Pharmazie; 1991 Aug; 46(8):597-9. PubMed ID: 1798716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antistaphylococcal and antifibrinolytic activities of omega-amino acids and their L-histidine dipeptides.
    Fujii A; Tanaka K; Tsuchiya Y; Cook ES
    J Med Chem; 1971 Apr; 14(4):354-7. PubMed ID: 5553750
    [No Abstract]   [Full Text] [Related]  

  • 20. [The action of fibrinolysis inhibitors of the omega-aminocarboxylic acid type on the proliferation of in vitro cultured endothelial cells].
    Pilgrim H
    Pharmazie; 1986 Jul; 41(7):519-20. PubMed ID: 3490674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.